22.70

3.77% -0.89

After Hours: 22.95 0.25 +1.10%

Caredx Inc (CDNA)

Overview News Price History Option Chain Financials Discussions Forecast

Caredx Inc stock is traded at $22.70, with a volume of 479.85K. It is down -3.77% in the last 24 hours and down -2.74% over the past month. CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre-and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates major revenue from the Testing services.

Previous Close:

$23.59

Open:

$23.62

24h Volume:

479.85K

Relative Volume:

0.64

Market Cap:

$1.22B

Revenue:

$312.78M

Net Income/Loss:

$-143.56M

P/E Ratio:

-8.4387

EPS:

-2.69

Net Cash Flow:

$1.22M

1W Performance:

-1.22%

1M Performance:

-2.74%

6M Performance:

-9.24%

1Y Performance:

+152.22%

1-Day Range:

$22.50

$23.65

1-Week Range:

$22.21

$23.81

52-Week Range:

$7.42

$34.84

Caredx Inc Stock (CDNA) Company Profile

Name

Caredx Inc

Sector

Healthcare (1177)

Industry

Diagnostics & Research (60)

Phone

415-287-2300

Address

8000 MARINA BLVD, BRISBANE, CA

Employee

643

Twitter

Next Earnings Date

2024-11-04

Latest SEC Filings

CDNA's Discussions on Twitter

Compare CDNA with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
CDNA Caredx Inc	22.70	1.22B	312.78M	-143.56M	1.22M	-2.69
TMO Thermo Fisher Scientific Inc	572.71	219.06B	42.88B	6.34B	7.27B	16.53
DHR Danaher Corp	210.01	151.02B	23.88B	3.90B	5.30B	5.28
A Agilent Technologies Inc	147.64	42.12B	6.51B	1.29B	1.37B	4.42
IQV Iqvia Holdings Inc	209.96	38.11B	15.32B	1.41B	1.96B	7.62
IDXX Idexx Laboratories Inc	460.56	37.71B	3.84B	866.24M	792.60M	10.37

Caredx Inc Stock (CDNA) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jan-15-25	Upgrade	Wells Fargo	Underweight → Equal Weight
Aug-28-24	Initiated	Wells Fargo	Underweight
Aug-19-24	Upgrade	BTIG Research	Neutral → Buy
May-13-24	Downgrade	Raymond James	Outperform → Mkt Perform
May-01-24	Upgrade	Craig Hallum	Hold → Buy
Nov-09-23	Upgrade	Stephens	Equal-Weight → Overweight
Aug-15-23	Upgrade	Raymond James	Mkt Perform → Outperform
May-11-23	Downgrade	BTIG Research	Buy → Neutral
Mar-07-23	Downgrade	Stephens	Overweight → Equal-Weight
Mar-03-23	Downgrade	Craig Hallum	Buy → Hold
Mar-03-23	Downgrade	Raymond James	Strong Buy → Mkt Perform
Apr-25-22	Initiated	Stephens	Overweight
Jul-20-21	Resumed	BTIG Research	Buy
Jun-03-21	Initiated	Goldman	Buy
Feb-26-21	Downgrade	H.C. Wainwright	Buy → Neutral
Oct-30-20	Reiterated	H.C. Wainwright	Buy
Oct-08-20	Reiterated	H.C. Wainwright	Buy
Oct-02-20	Reiterated	H.C. Wainwright	Buy
Aug-05-20	Reiterated	H.C. Wainwright	Buy
Jun-26-20	Initiated	BTIG Research	Buy
Jun-19-20	Reiterated	H.C. Wainwright	Buy
Oct-01-19	Resumed	Craig Hallum	Buy
May-09-19	Upgrade	H.C. Wainwright	Neutral → Buy
Feb-15-19	Initiated	Jefferies	Buy
Oct-23-18	Resumed	Raymond James	Strong Buy
Sep-18-18	Reiterated	H.C. Wainwright	Neutral
Nov-27-17	Initiated	H.C. Wainwright	Buy
Jun-14-16	Reiterated	Mizuho	Buy
Sep-29-15	Downgrade	Raymond James	Outperform → Mkt Perform
Sep-25-15	Initiated	Craig Hallum	Buy
Mar-18-15	Reiterated	Mizuho	Buy